Conduit Pharmaceuticals Inc. Capital Reinvestment Ratio

Latest as of June 2026: 0.95x

Conduit Pharmaceuticals Inc. capital reinvestment ratio. Conduit Pharmaceuticals Inc. (CDT) has a Capital Reinvestment Ratio of 0.95x as of June 2026, meaning it reinvests 1% of its operating cash flow ($42.74 Million) in capital expenditures ($40.66 Million). Check Conduit Pharmaceuticals Inc. (CDT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.95x

Capex / Operating Cash Flow

Operating Cash Flow

$42.74 Million

USD

Capital Expenditures

$40.66 Million

USD

Data as of

Jun 2026

Most recent filing

Conduit Pharmaceuticals Inc. Capital Reinvestment Ratio by Year (None–None)

Conduit Pharmaceuticals Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see CDT cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow